Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare I2 CHF AccFür den Zugriff auf unsere Ratings hier anmelden |
Wie hat sich dieser Fonds entwickelt? | 31.10.2024 |
Wachstum von 1000 (EUR) | Charts Erweitert |
Fonds | 35,2 | -5,9 | -18,4 | -10,3 | 0,7 | |
+/-Kat | 24,0 | -22,6 | -8,6 | -9,5 | -5,8 | |
+/-Idx | - | -32,0 | -18,5 | -10,1 | -9,5 | |
Kategorie: Branchen: Gesundheitswesen | ||||||
Kategorie Benchmark: Morningstar Gbl Health TME ... |
Übersicht | ||
NAV 21.11.2024 | CHF 140,72 | |
Änderung z. Vortag (in EUR) | 0,10% | |
Ausgabeaufschlag | - | |
Morningstar Kategorie™ | Branchen: Gesundheitswesen | |
WKN | A2DPA5 | |
ISIN | LU1587985067 | |
Fondsvolumen (Mio) 21.11.2024 | USD 119,07 | |
Anteilsklassenvol (Mio) - | - | |
Ausgabeaufschlag (max.) | 5,00% | |
Laufende Kosten 31.01.2024 | 1,40% |
Anlageziel: Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare I2 CHF Acc |
The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of the Asia-Pacific region. The universe for companies is determined cumulatively as follows: Shares of companies that have their registered office or carry out the majority of their economic activity in the healthcare sector in the Asia-Pacific region. These include companies operating in such areas as generics, medtech, biotech, pharma and health services which are involved in the development, manufacture or sale of products and services. Listed on a recognised stock market or, in the case of an initial public offering, the company has applied for listing on the relevant exchange. |
Returns | |||||||||||||
|
Management | ||
Fondsmanager Startdatum | ||
Oliver Kubli 28.04.2017 | ||
Remo Krauer 01.09.2018 | ||
Anteilserstausgabe 28.04.2017 |
Werbung |
Kategorie Benchmark | |
Fondsbenchmark | Morningstar Benchmark |
MSCI Asia Pacific Healthcare NR CHF | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Was steckt in diesem Fonds? Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare I2 CHF Acc | 31.10.2024 |
|
|
Top 5 Positionen | Sektor | % |
Daiichi Sankyo Co Ltd | Gesundheitswesen | 8,41 |
Hoya Corp | Gesundheitswesen | 6,40 |
CSL Ltd | Gesundheitswesen | 5,90 |
Otsuka Holdings Co Ltd | Gesundheitswesen | 5,01 |
Olympus Corp | Gesundheitswesen | 4,88 |
aufgestockt reduziert neu seit letztem Portfolio | ||
Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare I2 CHF Acc |